Revolutionary Cancer Treatment: The World’s First Cancer-Killing Nanorobots
A Groundbreaking Study
A recent study from Chinese researchers has made significant strides in cancer treatment by merging biology with nano-engineering. Published in Nature Biotechnology, this research introduces nanorobots that target and block blood flow to tumors, effectively starving them of essential nutrients.
Innovative DNA Origami Technology
The researchers employed a technique known as “DNA origami,” which involves folding DNA sheets into tubular structures, referred to as nanorobots. These nanorobots are designed to store therapeutic agents. In this case, they encapsulated thrombin, a protein that induces blood coagulation in nearby vessels when released, thus obstructing blood flow.
Targeting Cancer Cells
To ensure the nanorobots effectively target cancer cells, the scientists coated them with specific molecules that adhere to nucleolin, a protein prevalent in cancerous blood vessels. Upon binding to these cells, the DNA structures unfold, releasing thrombin and cutting off the blood supply to tumors.
Significant Reduction in Tumor Growth
In trials involving mice with human breast cancer, the nanorobots significantly slowed tumor growth. Within 24 hours of treatment, blood in the vessels surrounding the tumors coagulated, preventing cancer cells from receiving vital nutrients. Survival rates improved notably, with breast cancer mice living an average of 39 days, compared to 29 days without treatment. Similarly, mice with melanoma experienced an increase in survival from 20.5 days to 45 days.
Safety and Efficacy
The design of these nanorobots ensured that only cancerous blood vessels were affected, leaving healthy vessels unharmed. Additionally, as the robots are composed of biological materials, they do not trigger adverse immune responses, and their components can be broken down by the liver.
Future Potential for Human Applications
Beyond slowing tumor growth, the nanorobots also prevented the metastasis of cancerous cells to other areas. Although they did not eliminate cancer on their own, the researchers suggest that combining this approach with mild chemotherapy or radiation could enhance effectiveness.
The authors of the study express hope that their nanorobot design will encourage further research into similar treatments for human trials. This innovative method holds potential for addressing various human disorders by effectively delivering life-saving drugs to targeted cells.
Reference
Li, S., et al. (2018). A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo. Nature Biotechnology. doi:10.1038.